Roundup: Personify Care integrates pulse oximeter data, India-based MyHealthcare launches speciality EMRs and more briefs

Personify Care enables pulse oximeter integration with patient management platform

Personify Care has integrated blood oxygen saturation data from iHealth’s wireless pulse oximeters into its patient management software to support remote COVID-19 patient monitoring. 

The company noted in a statement that the remote monitoring of blood oxygen saturation levels is a key requirement to enable virtual models of care for COVID-19 patients in home isolation. 

Its users in health services can now allow their clinical staff to remotely monitor patients. They can configure alerts based on their own protocols, get notified when reading is beyond a specified threshold, and follow up with patients via secure messaging. 

Their patients are then empowered to “seamlessly” send their vital signs data to their care team. Through its platform, patients can also report symptoms, receive instructions on self-health management, and communicate with clinical staff.

“By detecting risks and issues early, the aim is to improve patient health outcomes while reducing the burden on frontline healthcare teams,” the company said.

Personify Care’s platform uses data-driven models to enable the adoption of digital pathways for patients at scale. It mentioned that over the past year, it delivered a 90% patient response rate among 6.4 million patient interactions across healthcare settings in Australia, New Zealand and globally. 

Indian online healthcare provider unveils speciality EMRs

MyHealthcare, an Indian digital healthcare provider, has introduced new electronic medical records for various healthcare specialities.

The startup collaborated with specialists in building each EMR for cardiology, paediatrics, endocrinology, obstetrics and gynaecology and ENT. These digital clinical solutions have been integrated across a comprehensive healthcare data lake, made possible by MyHealthcare’s partnership with global tech providers like Amazon and Microsoft. 

Serving as an assistive clinical tool, the speciality EMRs host an expansive library of care protocols, a formulary database of over 19,000 drugs, and feature an AI-powered voice-to-text engine for recording clinical notes and diagnosis information. 

Based on a patient’s medical history and diagnostic report, each EMR provides trend analysis, clinical markers and alerts, guiding doctors to focus on areas where they can improve the effectiveness of their care. 

My Healthcare’s EMR platform, according to a news report, has been integrated across a network of diagnostic providers, including Healthian, Dr Lal Path Labs and Metropolis, as well as home care providers. 

Over the coming months, MyHealthcare CEO Shyatto Raha announced, the startup will introduce EMRs for IVF, oncology, neurology and others. “We are working to expand our provider network, with more hospitals, speciality clinics, diagnostics and pharmacy providers,” he added.

Visionflex, Syndeticom provide latest mobile telehealth solution to healthcare providers

Telehealth firm Visionflex and digital infrastructure specialist Syndeticom have partnered to offer a new mobile telehealth solution for Australian healthcare providers.

The company has started rolling out their latest telehealth product to care centres across Western NSW and Far West NSW local health districts.

Following this, the partners will expand their offering across the country, said Mike Harman, co-founder and CEO of Visionflex.

“Having the ability to simply and effectively perform clinical examinations via video conferencing lifts the bar in telehealth expectations and leads to increased efficiencies in the health sector,” he said.

Commenting on their partnership, Syndeticom General Manager Duncan MacLennan said: “This exciting new partnership opens a whole new level of opportunities for the growing Australian telehealth market to procure Australian designed and manufactured telehealth infrastructure without the cost, time and quality limitations and inconsistencies experienced in procuring overseas”.